-
Mashup Score: 1
With adoptive cell therapy, Fox Chase Cancer center is working to advance what’s possible in personalized cancer treatement.
Source: Philadelphia MagazineCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1This Deadly Blood Clot Is Vastly Underdiagnosed. A Groundbreaking Team of Philly Physicians Want to Change That [Sponsor Content] - 2 year(s) ago
These Philly heroes are working to save thousands of lives by enhancing awareness of this condition and improving its treatment day in and day out.
Source: Philadelphia MagazineCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2
Through the study of epigenetics, Fox Chase’s Sarcoma Medical Oncology program hopes to develop a better understanding of cancer — and generate life-saving treatments through team-wide collaboration.
Source: Philadelphia MagazineCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0This Philly “Super-Team” Is Working To Decode One of the Most Mysterious, Dangerous Cancers - Philadelphia Magazine - 3 year(s) ago
Our best shot at neutralizing cancer is not necessarily a cure. Cancer is a vast, complex disease, and the battle between the body and the […]
Source: Philadelphia MagazineCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The First FDA-Approved Cell Therapy for Multiple Myeloma Is Now Being Offered at Fox Chase - 3 year(s) ago
The Northeast Philadelphia cancer center will offer Abecma — a CAR T-cell therapy targeting myeloma cells — to patients who have previously tried at least four different treatments.
Source: Philadelphia MagazineCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1This Philly “Super-Team” Is Working To Decode One of the Most Mysterious, Dangerous Cancers - Philadelphia Magazine - 3 year(s) ago
Our best shot at neutralizing cancer is not necessarily a cure. Cancer is a vast, complex disease, and the battle between the body and the […]
Source: Philadelphia MagazineCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The First FDA-Approved Cell Therapy for Multiple Myeloma Is Now Being Offered at Fox Chase - 3 year(s) ago
The Northeast Philadelphia cancer center will offer Abecma — a CAR T-cell therapy targeting myeloma cells — to patients who have previously tried at least four different treatments.
Source: Philadelphia MagazineCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
The Fox Chase Cancer Center senior director of community outreach recently co-authored a paper on ways to decrease cancer care disparities in medically underserved communities in America.
Source: Philadelphia MagazineCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
After decades of struggle, we’re finally seeing real-world, life-changing applications right here in Philadelphia. Has medicine finally got gene therapy right?
Source: Philadelphia MagazineCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 2This New Ultrasound Technology at Fox Chase Could Help the Thousands of Men Living with Prostate Cancer [Sponsor Content] - 3 year(s) ago
To many men and their loved ones, the prospect of prostate cancer is frightening. It’s the second most common cancer among men, and treatment can […]
Source: Philadelphia MagazineCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Researchers at Fox Chase are conducting a study on adoptive cell therapy. “We’re paving the road for potentially a paradigm shift in the way that we offer therapy to patients,” Fox Chase's Dr. Anthony Olszanski tells @phillymag. Learn about the trial: https://t.co/yljQmons4m